Q2 2017

Filed Aug 11, 2017 · 10-Q · 42 days after period end · 0001477932-17-003857

Q2 2017 · 10-Q

Revenue

$210.54K

+12.0% vs Q2 2016

Net Income

$11.30M

N/M vs Q2 2016

EPS Diluted

$0.02

N/M vs Q2 2016

Operating Income-$786,618N/M

Operating Cash Flow

Same quarter

Metric	Q2 2017	Q2 2016	Q2 2015	Q2 2014
Revenue	$210.54K	$187.91K	$457.78K	$238.01K
Net Income	$11.30M	-$1.07M	-$3.77M	$339.58K
EPS Diluted	$0.02	-$0.01	-$0.02	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR